Polar Capital Global Healthcare Trust

What Polar Capital Global Healthcare Trust does

Polar Capital Global Healthcare Trust plc (LSE: PCGH) is a UK-listed investment trust launched in June 2010 with the investment objective of generating capital growth through a global portfolio of healthcare equities. The trust invests across all four healthcare sub-sectors — pharmaceuticals, biotechnology, medical devices, and healthcare services — with notable disclosed positions in Eli Lilly & Co and AstraZeneca PLC. Portfolio construction is actively managed by an eight-strong specialist healthcare team at Polar Capital, and the trust reported total assets of £411.5m as of 29 May 2026.

The business is structured as a closed-end investment vehicle: shares trade on the London Stock Exchange and are accessible to investors through any UK stockbroker, platform, or financial adviser that supports UK-listed securities. Revenue mechanics for the trust itself are derived from dividend income and capital appreciation within the underlying portfolio, which flows through to shareholders via net asset value (NAV) growth and share price performance rather than a fee-for-service model. The trust does not publish traditional revenue figures; AUM is the primary disclosed financial metric.

In November 2025 the trust executed a coordinated restructuring package: the fixed-life structure was removed in favour of a rolling five-year tender offer mechanism, performance fees were eliminated, and a new allocation policy was introduced permitting up to 30% exposure to small- and mid-cap companies. Approximately 80% of shareholders elected to remain invested following the tender offer, indicating strong endorsement of the revised mandate.

Name

Polar Capital Global Healthcare Trust

Legal name

Polar Capital Global Healthcare Trust plc

Website

https://polarcapitalhealthcaretrust.com

Company type

Public

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Polar Capital Global Healthcare Trust plc (LSE: PCGH) is a UK-listed investment trust investing globally in healthcare stocks across all four sub-sectors, managed by an eight-strong specialist team at Polar Capital to generate capital growth for UK retail and institutional investors.

Ownership category

akta.pro rank

Product category

Healthcare Investment Trust

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

Keywords

• Healthcare investment trust
• Global healthcare equities
• Specialist asset management
• Closed-end fund
• Active portfolio management

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Others

Revenue model

1. Investment Returns (NAV Growth and Share Price Appreciation): As a publicly listed investment trust, the company generates returns for shareholders through appreciation in the net asset value of its underlying portfolio of global healthcare equities, and through share price performance on the London Stock Exchange. Revenue is derived from dividend income and capital gains on the portfolio.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Polar Capital Global Healthcare Trust plc is a UK-listed closed-ended investment trust that generates capital growth by investing in a globally diversified portfolio of healthcare equities across all four healthcare sub-sectors (pharmaceuticals, biotechnology, medical devices, and healthcare services). The trust is actively managed by Polar Capital's specialist eight-strong healthcare team and holds positions in major global healthcare companies including Eli Lilly & Co and AstraZeneca PLC.

Product overview

Polar Capital Global Healthcare Trust is a single, unified investment trust product that invests in a global portfolio of healthcare stocks. The trust covers all four healthcare sub-sectors and is managed by an eight-strong specialist healthcare team at Polar Capital. The trust's net asset value has grown over 80% since its 2017 reconstruction, with total assets of £411.5m.

Differentiator

Problem solved

Functional benefit

Products and services

• Polar Capital Global Healthcare Trust (PCGH) An actively managed global investment trust that generates capital growth by investing in a diversified portfolio of healthcare stocks across all four healthcare sub-sectors, including major positions in companies such as Eli Lilly & Co and AstraZeneca PLC. The trust is listed on the London Stock Exchange under ticker PCGH and is available to retail and institutional investors through stockbrokers, investment platforms, and financial advisors.

Quantifiable outcome

• Net asset value grew over 80% since 2017 reconstruction
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• BB Healthcare Trust: UK-listed closed-end investment trust investing in global healthcare equities, with a comparable single-strategy healthcare mandate and UK retail/advisor distribution model.
• Worldwide Healthcare Trust: UK-listed investment trust managed by OrbiMed focused on global healthcare equities; directly comparable in mandate, structure, and target investor base to PCGH.
• International Biotechnology Trust: UK-listed investment trust focused on biotechnology equities; a directly comparable vehicle referenced in PCGH's own materials as a beneficiary of biotech M&A tailwinds.
• RTW Biotech Opportunities: Biotech-focused investment vehicle referenced in PCGH's own materials; comparable as a healthcare/biotech specialist trust with overlapping investor audience.
• Syncona Limited: UK-listed life sciences investment company; comparable as a healthcare-focused listed investment vehicle with overlapping sub-sector exposure.
• Biotech Growth Trust: UK-listed trust (ticker BIOG) referenced in PCGH's own materials; a focused biotech investment trust with similar listed-trust structure and UK distribution.

Broad incumbents

• Polar Capital Technology Trust: Sibling trust under the Polar Capital investment trust umbrella; same management group, listed-trust structure, and UK distribution, but focused on global technology equities rather than healthcare.
• Polar Capital Global Financials Trust: Another sibling trust under the Polar Capital umbrella with the same listed-trust structure and distribution model, but focused on global financials rather than healthcare.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Polar Capital Global Healthcare Trust